Analyzing clinical characteristics of pituitary diseases
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
Peking Union Medical College Hospital · NCT06435195
This study looks at the health details and treatment results of patients with rare pituitary diseases to help doctors understand these conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06435195 on ClinicalTrials.gov |
What this trial studies
This observational study aims to systematically describe the clinical characteristics and outcomes of patients with pituitary complex and rare diseases at Peking Union Medical College Hospital. Researchers will conduct detailed clinical evaluations, gather medical histories, and perform follow-up assessments to monitor disease progression and treatment outcomes. The study will compare different patient groups to identify significant differences in remission rates, comorbidities, perioperative events, and radiological findings. By leveraging a large cohort, the research seeks to enhance understanding and inform clinical practice regarding these conditions.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with rare sellar diseases such as pituitary adenomas, craniopharyngiomas, and other related conditions.
Not a fit: Patients with incomplete medical records or unrelated primary central nervous system diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and prognosis of patients with pituitary complex and rare diseases.
How similar studies have performed: While similar studies have explored pituitary diseases, this comprehensive observational approach focusing on rare conditions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with rare sellar diseases including but not limited to pituitary adenomas (such as Thyrotropin-secreting pituitary adenomas, GH-secreting adenomas), craniopharyngiomas, Rathke's cleft cysts, sellar region germ cell tumors, cavernous sinus syndrome, and other diseases * Detailed medical history, including clinical symptoms, treatment plans and follow-up outcomes Exclusion Criteria: * Incomplete medical records, especially missing key imaging diagnostic results * Patients with coexisting primary central nervous system diseases unrelated to sellar region diseases (such as severe traumatic brain injury) * Patients whose sellar region pathological diagnosis was changed or overturned during the follow-up period
Where this trial is running
Beijing, Beijing Municipality
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Principal investigator: Yong Yao, MD — Department of Neurosurgery, Peking Union Medical College Hospital
- Study coordinator: Yong Yao, MD
- Email: yaoyong@pumch.cn
- Phone: +8669152530
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pituitary Diseases